Overview
Anna-maria Fink practices in Koeln, Germany. Ms. Fink is rated as a Distinguished expert by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Her top areas of expertise are Small Lymphocytic Lymphoma (SLL), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Leukemia.
Her clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 57 articles in the study of Chronic Lymphocytic Leukemia (CLL).
Locations
Duesseldorf, NW, Germany
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Ms. Fink isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Fink isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Small Lymphocytic Lymphoma (SLL)Ms. Fink isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- LeukemiaMs. Fink isAdvanced. Learn about Leukemia.
- Experienced
- Adult T-Cell LeukemiaMs. Fink isExperienced. Learn about Adult T-Cell Leukemia.
- Chronic T-Cell Leukemia (CTCL)Ms. Fink isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Lymphofollicular HyperplasiaMs. Fink isExperienced. Learn about Lymphofollicular Hyperplasia.
- Prolymphocytic LeukemiaMs. Fink isExperienced. Learn about Prolymphocytic Leukemia.